ArticleJournal of materials science. Materials in medicine2025
Synthesis and characterization of clove/gelatin coated silk sutures for surgical site infection and wound healing.
Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolomic profiling of indigenous lactic acid bacteria reveals functional traits shaping the flavor and bioactivity of Ecuadorian coffee.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Surgical Site infections (SSIs) affect up to 5% of surgical procedures, posing a significant postoperative complication. This study aims to develop and evaluate antibacterial clove/gelatin-coated sutures to reduce SSI infection. Clove extract, known for its antimicrobial properties, was incorporated into a gelatin matrix as a biocompatible coating for silk-braided sutures. Sutures were dip-coated in clove/gelatin solutions at concentrations of 5, 10, 15, and 20%. The surface morphology, chemical composition, and mechanical strength of the coated suture were characterized by using scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), and tensile testing. Antimicrobial efficacy was assessed via zone-of-inhibition assays against (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis). The 20% Clove/gelatin coating exhibited the highest antibacterial activity (17.5 ± 0.875 mm) and demonstrated low cytotoxicity in MTT assay with human primary dermal fibroblast. Hemolytic assays revealed that all composite concentrations resulted in <1% hemolytic activity. Approximately 93% of drug release was observed in 20% formulation within 72 h which is promising results compared with untreated sutures. Based on its superior antibacterial performance, the 20% formulation was selected for in vivo studies. In a rat abdominal incision model, wounds closed with coated sutures exhibited complete healing, while those closed with uncoated sutures remained partially healed. These findings highlight the potential of clove/gelatin-coated sutures for enhanced antimicrobial protection and improved wound healing in surgical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.